{
    "id": 25549,
    "fullName": "KIT P551_E554del",
    "impact": "deletion",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "KIT P551_E554del results in the deletion of 4 amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 551 to 554 (PMID: 16226710). P551_E554del has not been characterized, however similar Kit exon 11 deletions are activating, thus P551_E554del is predicted to lead to a gain of Kit protein function (PMID: 9438854, PMID: 15365079).",
            "references": [
                {
                    "id": 2054,
                    "pubMedId": 15365079,
                    "title": "Biology of gastrointestinal stromal tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15365079"
                },
                {
                    "id": 650,
                    "pubMedId": 9438854,
                    "title": "Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9438854"
                },
                {
                    "id": 648,
                    "pubMedId": 16226710,
                    "title": "Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16226710"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3815,
        "geneSymbol": "KIT",
        "terms": [
            "KIT",
            "C-Kit",
            "CD117",
            "MASTC",
            "PBT",
            "SCFR"
        ]
    },
    "variant": "P551_E554del",
    "createDate": "10/19/2016",
    "updateDate": "05/14/2019",
    "referenceTranscriptCoordinates": {
        "id": 136514,
        "transcript": "NM_000222",
        "gDna": "chr4:g.54727419_54727430del12",
        "cDna": "c.1651_1662del12",
        "protein": "p.P551_E554delPMYE",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6777,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT P551_E554del were resistant to treatment with Gleevec (imatinib) in culture (PMID: 25239608).",
            "molecularProfile": {
                "id": 26563,
                "profileName": "KIT P551_E554del"
            },
            "therapy": {
                "id": 770,
                "therapyName": "Imatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3860,
                    "pubMedId": 25239608,
                    "title": "Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25239608"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6774,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT P551_E554del demonstrated sensitivity to treatment with Iclusig (ponatinib) in culture, resulting in reduced cell viability (PMID: 25239608).",
            "molecularProfile": {
                "id": 26563,
                "profileName": "KIT P551_E554del"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3860,
                    "pubMedId": 25239608,
                    "title": "Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25239608"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6778,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT P551_E554del were resistant to treatment with Stivarga (regorafenib) in culture (PMID: 25239608).",
            "molecularProfile": {
                "id": 26563,
                "profileName": "KIT P551_E554del"
            },
            "therapy": {
                "id": 890,
                "therapyName": "Regorafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3860,
                    "pubMedId": 25239608,
                    "title": "Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25239608"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6776,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing KIT P551_E554del were resistant to treatment with Sutent (sunitinib) in culture (PMID: 25239608).",
            "molecularProfile": {
                "id": 26563,
                "profileName": "KIT P551_E554del"
            },
            "therapy": {
                "id": 930,
                "therapyName": "Sunitinib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 3860,
                    "pubMedId": 25239608,
                    "title": "Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25239608"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26563,
            "profileName": "KIT P551_E554del",
            "profileTreatmentApproaches": [
                {
                    "id": 10688,
                    "name": "KIT Inhibitor",
                    "profileName": "KIT P551_E554del"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 136520,
            "transcript": "XM_017008180",
            "gDna": "chr4:g.54727433_54727444del12",
            "cDna": "c.1653_1664del12",
            "protein": "p.Q552_V555delQWKV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136521,
            "transcript": "XM_005265742",
            "gDna": "chr4:g.54727428_54727439del12",
            "cDna": "c.1651_1662del12",
            "protein": "p.E551_W554delEVQW",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136518,
            "transcript": "XM_017008179",
            "gDna": "chr4:g.54727428_54727439del12",
            "cDna": "c.1651_1662del12",
            "protein": "p.E551_W554delEVQW",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136514,
            "transcript": "NM_000222",
            "gDna": "chr4:g.54727419_54727430del12",
            "cDna": "c.1651_1662del12",
            "protein": "p.P551_E554delPMYE",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136515,
            "transcript": "NM_001093772",
            "gDna": "chr4:g.54727433_54727444del12",
            "cDna": "c.1653_1664del12",
            "protein": "p.Q552_V555delQWKV",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136519,
            "transcript": "XM_017008178",
            "gDna": "chr4:g.54727419_54727430del12",
            "cDna": "c.1651_1662del12",
            "protein": "p.P551_E554delPMYE",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136516,
            "transcript": "XM_005265740",
            "gDna": "chr4:g.54727416_54727427del12",
            "cDna": "c.1651_1662del12",
            "protein": "p.K551_Y554delKPMY",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 136517,
            "transcript": "XM_005265741",
            "gDna": "chr4:g.54727416_54727427del12",
            "cDna": "c.1651_1662del12",
            "protein": "p.K551_Y554delKPMY",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}